Another 3 Common Pesticides Are Now Linked To Parkinson’s Disease Risk

Translate to Spanish or other 102 languages!

Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease prevalence is growing fast, and similar to some other neurological conditions, its causes are unclear. 
  • The potential impact of chemicals that are toxic to neurons in the part of the brain affected by Parkinson’s disease has been investigated since the 1980s. 
  • Despite this, many chemicals, particularly pesticides and herbicides that are known to pose a risk, are still used in many parts of the world. 
  • Researchers have now identified a risk of Parkinson’s disease associated with exposure to 14 pesticides. 

Parkinson’s disease is the fastest growingTrusted Source neurological disorder in the world at present, and the reason why is unclear.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/another-3-common-pesticides-are-now-linked-to-parkinsons-disease-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.
- Advertisement -